SLC6A3 and Parkinson disease: Altered DAT activity is primarily implicated in neurological and neuropsychiatric diseases such as drug addiction, ADHD, autism and Parkinson disease (PD), but dysregulation of dopamine transmission is also associated with a host of peripheral functions, including regulation of blood pressure, insulin secretion and immune function [1,2,3,4,5,6,7,8].